➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

Express Scripts
Boehringer Ingelheim
Harvard Business School

Last Updated: July 13, 2020

DrugPatentWatch Database Preview

Drugs in Development Information for Pracinostat

Email this page to a colleague

» See Plans and Pricing

« Back to Dashboard

What is the development status for investigational drug Pracinostat?

Pracinostat is an investigational drug.

There have been 10 clinical trials for Pracinostat. The most recent clinical trial was a Phase 2 trial, which was initiated on June 1st 2017.

The most common disease conditions in clinical trials are Syndrome, Preleukemia, and Myelodysplastic Syndromes. The leading clinical trial sponsors are MEI Pharma, Inc., Helsinn Healthcare SA, and M.D. Anderson Cancer Center.

There are seven US patents protecting this investigational drug and sixty-seven international patents.

Recent Clinical Trials for Pracinostat
Pracinostat in Combination With Gemtuzumab Ozogamicin (PraGO) in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML)Medical College of WisconsinPhase 1
A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The BodyQuotient SciencesPhase 1
A Study In Healthy Male Volunteers Designed To Investigate How A Radiolabelled Medicine Is Broken Down And Removed From The BodyHelsinn Healthcare SAPhase 1

See all Pracinostat clinical trials

Clinical Trial Summary for Pracinostat

Top disease conditions for Pracinostat
Top clinical trial sponsors for Pracinostat

See all Pracinostat clinical trials

US Patents for Pracinostat

Drugname Patent Number Patent Title Patent Assignee Estimated Expiration
Pracinostat   Start Trial Heterocyclic compounds S*BIO Pte Ltd. (Singapore Science Park II, SG)   Start Trial
Pracinostat   Start Trial Methods and compositions for treatment of autism The Johns Hopkins University (Baltimore, MD) Kennedy Krieger Institute, Inc. (Baltimore, MD)   Start Trial
Pracinostat   Start Trial RbAp48 transgenic mice for drug discovery in age-related memory decline THE TRUSTEES OF COLUMBIA UNIVERSITY IN THE CITY OF NEW YORK (New York, NY)   Start Trial
Pracinostat   Start Trial System and method of producing volatile organic compounds from fungi   Start Trial
Pracinostat   Start Trial Method of treating leukemia using pharmaceutical formulation containing thienotriazolodiazepine compounds Merck Sharp & Dohme Corp. (Rahway, NJ)   Start Trial
>Drugname >Patent Number >Patent Title >Patent Assignee >Estimated Expiration

International Patents for Pracinostat

Drugname Country Document Number Estimated Expiration Related US Patent
Pracinostat Argentina 055364 2025-09-08   Start Trial
Pracinostat Argentina 105930 2025-09-08   Start Trial
Pracinostat Austria 512953 2025-09-08   Start Trial
Pracinostat Australia 2006201177 2025-09-08   Start Trial
Pracinostat Brazil PI0615690 2025-09-08   Start Trial
>Drugname >Country >Document Number >Estimated Expiration >Related US Patent

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:


Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.